Close

ACOR Financial Facts

Total net revenues: 135.61M
Interest and amortization of debt discount expense: -4.4M
See Full Income Statement

Non-current portion of deferred license revenue: 34.72M
Accumulated deficit: -240.88M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date N/A EPS Growth Rate -139.7% *Last Qtr.
Average EPS % Beat Rate -188.2% Revenue Growth Rate +63.1% *Last Qtr.
Average % Move 1-Wk after EPS -8.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/22/15 Q315 $0.31$0.15 +$0.16$148.2M$115.52M N/A Details
10/31/18 Q318 $0.17-$0.02 +$0.19$142.81M$82.81M = Details
5/2/19 Q119 -$0.56-$0.94 +$0.38$44.14M$33.04M = Details
2/13/14 Q413 $0.32$0.18 +$0.14$92.59M$89.96M N/A Details
10/31/12 Q312 $0.38$0.10 +$0.28$77.44M$75.2M N/A Details
11/4/11 Q311 $0.40$0.73 -$0.33$93.03M$90.78M N/A Details
11/4/19 Q319 -$0.46-$0.51 +$0.05$47.7M$44.72M = Details
8/2/18 Q218 $1.40$0.72 +$0.68$153.3M$138.63M = Details